AAAAAA

   
Results: 1-10 |
Results: 10
Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma
Authors: Boss, EA Massuger, LFAG Verhoef, LCG Huisman, HJ Boonstra, H Barentsz, JO
Citation: Ea. Boss et al., Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma, J MAGN R I, 13(4), 2001, pp. 600-606
Vascular endothelial growth factor in ovarian cyst fluid
Authors: Boss, EA Massuger, LFAG Thomas, CMG Geurts-Moespot, A Boonstra, H Sweep, CGJ
Citation: Ea. Boss et al., Vascular endothelial growth factor in ovarian cyst fluid, CANCER, 91(2), 2001, pp. 371-377
High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid
Authors: Boss, EA Moolenaar, SH Massuger, LFAG Boonstra, H Engelke, UFH de Jong, JGN Wevers, RA
Citation: Ea. Boss et al., High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid, NMR BIOMED, 13(5), 2000, pp. 297-305
The role of MR imaging in invasive cervical carcinoma
Authors: Boss, EA Barentsz, JO Massuger, LFAG Boonstra, H
Citation: Ea. Boss et al., The role of MR imaging in invasive cervical carcinoma, EUR RADIOL, 10(2), 2000, pp. 256-270
Needless treatment for presumed malignancy
Authors: Thomas, CMG Massuger, LFAG Merkus, HMWM
Citation: Cmg. Thomas et al., Needless treatment for presumed malignancy, LANCET, 355(9216), 2000, pp. 1725-1725
An illustration of the clinical relevance of detecting human antimouse antibody interference by affinity chromatography
Authors: Koper, NP Massuger, LFAG Thomas, CMG Beyer, C Crooy, MJ
Citation: Np. Koper et al., An illustration of the clinical relevance of detecting human antimouse antibody interference by affinity chromatography, EUR J OB GY, 86(2), 1999, pp. 203-205
Cytologic examination to detect clear cell adenocarcinoma of the vagina orcervix
Authors: Hanselaar, AGJM Boss, EA Massuger, LFAG Bernheim, JL
Citation: Agjm. Hanselaar et al., Cytologic examination to detect clear cell adenocarcinoma of the vagina orcervix, GYNECOL ONC, 75(3), 1999, pp. 338-344
Leiomyomatosis peritonealis disseminata: Does malignant transformation occur? A literature review
Authors: Bekkers, RLM Willemsen, WNP Schijf, CPT Massuger, LFAG Bulten, J Merkus, JMWM
Citation: Rlm. Bekkers et al., Leiomyomatosis peritonealis disseminata: Does malignant transformation occur? A literature review, GYNECOL ONC, 75(1), 1999, pp. 158-163
Uterine malignant leiomyoblastoma (epithelioid leiomyosarcoma) during pregnancy
Authors: Bekkers, RLM Massuger, LFAG Van der Berg, PP van Haelst, UGJM Bulten, J
Citation: Rlm. Bekkers et al., Uterine malignant leiomyoblastoma (epithelioid leiomyosarcoma) during pregnancy, GYNECOL ONC, 72(3), 1999, pp. 433-436
Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration
Authors: Buijs, WCAM Tibben, JG Boerman, OC Molthoff, CFM Massuger, LFAG Koenders, EB Schijf, CPT Siegel, JA Corstens, FHM
Citation: Wcam. Buijs et al., Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration, EUR J NUCL, 25(11), 1998, pp. 1552-1561
Risultati: 1-10 |